Department of Pharmacy, the Third Xiangya Hospital of Central South University, Changsha 410013, China.
Acta Pharmacol Sin. 2018 Jan;39(1):59-73. doi: 10.1038/aps.2017.50. Epub 2017 Aug 3.
Recent evidence shows that resveratrol (RSV) may ameliorate high-glucose-induced cardiac oxidative stress, mitochondrial dysfunction and myocardial fibrosis in diabetes. However, the mechanisms by which RSV regulates mitochondrial function in diabetic cardiomyopathy have not been fully elucidated. Mitochondrial dysfunction contributes to cardiac dysfunction in diabetic patients, which is associated with dysregulation of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α). In this study we examined whether resveratrol alleviated cardiac dysfunction in diabetes by improving mitochondrial function via SIRT1-mediated PGC-1α deacetylation. T2DM was induced in rats by a high-fat diet combined with STZ injection. Diabetic rats were orally administered RSV (50 mg·kg·d) for 16 weeks. RSV administration significantly attenuated diabetes-induced cardiac dysfunction and hypertrophy evidenced by increasing ejection fraction (EF%), fraction shortening (FS%), ratio of early diastolic peak velocity (E velocity) and late diastolic peak velocity (A velocity) of the LV inflow (E/A ratio) and reducing expression levels of pro-hypertrophic markers ANP, BNP and β-MHC. Furthermore, manganese superoxide dismutase (SOD) activity, ATP content, mitochondrial DNA copy number, mitochondrial membrane potential and the expression of nuclear respiration factor (NRF) were all significantly increased in diabetic hearts by RSV administration, whereas the levels of malondialdehvde (MDA) and uncoupling protein 2 (UCP2) were significantly decreased. Moreover, RSV administration significantly activated SIRT1 expression and increased PGC-1α deacetylation. H9c2 cells cultured in a high glucose (HG, 30 mmol/L) condition were used for further analyzing the role of SIRT1/PGC-1α pathway in RSV regulation of mitochondrial function. RSV (20 μmol/L) caused similar beneficial effects in HG-treated H9c2 cells in vitro as in diabetic rats, but these protective effects were abolished by addition of a SIRT1 inhibitor sirtinol (25 μmol/L) or by SIRT1 siRNA transfection. In H9c2 cells, RSV-induced PGC-1α deacetylation was dependent on SIRT1, which was also abolished by a SIRT1 inhibitor and SIRT1 siRNA transfection. Our results demonstrate that resveratrol attenuates cardiac injury in diabetic rats through regulation of mitochondrial function, which is mediated partly through SIRT1 activation and increased PGC-1α deacetylation.
最近的证据表明,白藜芦醇(RSV)可能通过改善高糖诱导的心脏氧化应激、线粒体功能障碍和糖尿病心肌纤维化来改善糖尿病。然而,RSV 调节糖尿病心肌病中线粒体功能的机制尚未完全阐明。线粒体功能障碍导致糖尿病患者心脏功能障碍,这与过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)的失调有关。在这项研究中,我们通过 SIRT1 介导的 PGC-1α 去乙酰化来研究 RSV 是否通过改善线粒体功能来减轻糖尿病中的心脏功能障碍。通过高脂肪饮食联合 STZ 注射诱导 T2DM 大鼠。糖尿病大鼠口服给予 RSV(50mg·kg·d)16 周。RSV 给药显著减弱了糖尿病诱导的心脏功能障碍和肥厚,表现为射血分数(EF%)、缩短分数(FS%)、左心室流入早期舒张峰速度(E 速度)与晚期舒张峰速度(A 速度)的比值(E/A 比值)增加,以及促肥厚标志物 ANP、BNP 和β-MHC 的表达水平降低。此外,RSV 给药还显著增加了糖尿病心脏的锰超氧化物歧化酶(SOD)活性、ATP 含量、线粒体 DNA 拷贝数、线粒体膜电位和核呼吸因子(NRF)的表达,而丙二醛(MDA)和解偶联蛋白 2(UCP2)的水平则显著降低。此外,RSV 给药还显著激活了 SIRT1 表达并增加了 PGC-1α 的去乙酰化。在高糖(HG,30mmol/L)条件下培养的 H9c2 细胞用于进一步分析 SIRT1/PGC-1α 通路在 RSV 调节线粒体功能中的作用。RSV(20μmol/L)在体外对 HG 处理的 H9c2 细胞产生了类似的有益作用,与糖尿病大鼠相似,但这些保护作用被 SIRT1 抑制剂 sirtinol(25μmol/L)或 SIRT1 siRNA 转染所消除。在 H9c2 细胞中,RSV 诱导的 PGC-1α 去乙酰化依赖于 SIRT1,这也被 SIRT1 抑制剂和 SIRT1 siRNA 转染所消除。我们的结果表明,白藜芦醇通过调节线粒体功能减轻糖尿病大鼠的心脏损伤,这部分是通过 SIRT1 激活和增加 PGC-1α 去乙酰化来介导的。
Oxid Med Cell Longev. 2017-8-13
Biochem Biophys Res Commun. 2021-3-26
Front Endocrinol (Lausanne). 2025-7-7
Mol Biomed. 2025-6-19
Naunyn Schmiedebergs Arch Pharmacol. 2025-3-18
Cardiovasc Drugs Ther. 2025-1-9
Int J Biochem Cell Biol. 2016-9-25
BMC Cardiovasc Disord. 2016-1-11
Int J Cardiol. 2016-1-1